FTC Contests Impax's Defense Of Opana ER Patent Settlement

Impax Laboratories Inc. has no pro-competitive justifications for its 2010 patent dispute settlement with Endo Pharmaceuticals Inc. over the drug Opana ER, and none of its defenses of the agreement's alleged...

Already a subscriber? Click here to view full article